Southwest Consulting Associates Blog

Brennan Newell

Find me on:

Recent Posts

340B Corner: Senate HELP Committee Hearing on the 340B Program

Posted by Brennan Newell on Apr 2, 2018 1:25:09 PM

The Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing March 15, 2018, with witnesses from America's Essential Hospitals, Carolina Health Centers, Inc., American Society of Health-System Pharmacists, and the Pharmaceutical Research and Manufacturers of America. The committee asked pertinent questions regarding the purpose and transparency of the 340B drug discount program to the following individuals:

Read More

Topics: 340B, 340b compliance, Senate HELP

Southwest Consulting Associates Partners With HAPevolve

Posted by Brennan Newell on Feb 12, 2018 12:58:14 PM

Southwest Consulting Associates is pleased to announce their Associate Membership with HAPevolve, of the Hospital & Healthsystem Association of Pennsylvania (HAP) effective immediately. The partnership is expected to enhance the value the Hospital & Health System Association of Pennsylvania offers its hospital members through reimbursement savings optimization programs and education provided by Southwest Consulting Associates.

Read More

Topics: News & Events

Celebrating SCA's 3rd Blog-iversary

Posted by Brennan Newell on Nov 8, 2017 2:05:43 PM

It is fitting that the month of Thanksgiving also begins the 4th year of SCA's healthcare blog. We thank you, the readers, for being a part of our story as we share the latest in Medicare DSH reimbursement, Worksheet S-10 uncompensated care and 340B drug pricing program news. You trust us with your time, and we appreciate being a source of insight in this ever-changing industry. As we celebrate our 3rd anniversary and start to our 4th year, let's take a look at how far we have come, together.

Read More

Topics: DSH Reimbursement, Medicare DSH Reimbursement, 340B, S-10, worksheet s-10, blog

340B Corner: Government Accountability Office 340B Recommendations

Posted by Brennan Newell on Sep 19, 2017 9:29:59 AM

The Government Accountability Office (the audit, evaluation, and investigative arm of Congress) examines the use of public funds; evaluates federal programs and policies; and provides analyses, recommendations, and other assistance to help Congress make informed oversight, policy, and funding decisions. As part of their mandate, they monitor and review the 340B drug discount program to determine if there are any issues with integrity and oversight and offer recommendations for greater compliance. In 2011, the GAO gave specific recommendations for HRSA. How much has been done and what is next for the 340B program?

Read More

Topics: 340B, HRSA, GAO, Government Accountability Office

340B Corner: 340B OPAIS WEBINAR

Posted by Brennan Newell on Sep 6, 2017 2:15:00 PM

HRSA's Office of Pharmacy Affairs announced webinar dates for information on the registration portion of the new 340B drug discount program database, 340B OPAIS (Office of Pharmacy Affairs Information System). The registration part of 340B OPAIS will be released mid-September. Webinar date and times are as follows:


Read More

Topics: 340B, 340B database, OPAIS, 340B OPAIS

340B Corner: Mylan Finalizes Settlement for EpiPen Overcharging

Posted by Brennan Newell on Aug 24, 2017 2:30:00 PM


On Thursday, August 17, 2017, CMS posted a notice regarding the execution of a settlement agreement entered into August 16, 2017 on its website concerning Mylan Inc. and Mylan Specialty L.P., and 340B pricing for EpiPen. According to the notice, Mylan will reclassify EpiPen Auto-Injector and EpiPen Jr. Auto-Injector as brand name drugs consistent with the Medicaid statute and regulations. Mylan will use the reference price of the 3rd quarter of 1990 for the purpose of calculating inflationary payment rebates under the Medicaid Drug Rebate program. The changes will be retroactive to April 1, 2017.

Read More

Topics: 340B, Mylan, Settlement

340B Corner Feature: Turnkey Pharmacy Solutions Recaps 340B Coalition

Posted by Brennan Newell on Aug 21, 2017 4:15:00 PM

Rich Bucher and Rob Nahoopii, of Turnkey Pharmacy Solutions, a 340B audit and compliance firm, give their highlights and takeaways from the Summer 2017 340B Coalition.

Read More

Topics: 340B, 340B Coalition Conference

340B Corner: OPAIS ALERT

Posted by Brennan Newell on Aug 9, 2017 3:25:25 PM

HRSA's OPA announced its current 340B database will be offline beginning August 15, 2017 in anticipation of its new database, Office of Pharmacy Affairs Information System (OPAIS). How will this affect users?


The new 340B database, OPAIS, is expected to be up and running by October 1, 2017. More information on OPAIS and it's specifications can be found here.  


Read More

Topics: 340B, 340B database, OPAIS

340B Corner: Make Way for OPAIS, OPA's New 340B Database!

Posted by Brennan Newell on Aug 3, 2017 3:58:23 PM

The Health Resources and Services Administration (HRSA)’s Office of Pharmacy Affairs (OPA) has announced it will replace its current database with a new system, the Office of Pharmacy Affairs Information System (OPAIS). When launched, OPAIS will serve as the 340B registration and pricing system for covered entities and manufacturers. Estimated launch date is October 2017. Here are key takeaways of OPAIS from the 2017 340B Coalition Summer Conference session with Josh Volpe, Public Health Analyst at HRSA.

Read More

Topics: 340B, 340B recertification, 340b registration, 340B database, OPAIS

340B Corner: Energy & Commerce Committee Hearing “Examining HRSA’s Oversight of the 340B Drug Pricing Program” Part 2

Posted by Brennan Newell on Jul 23, 2017 5:14:00 PM

We posted last week that the E&C Committee held a hearing July 18, 2017, with witnesses from the Office of Pharmacy Affairs, the Government Accountability Office and the Office of Inspector General. The purpose of the hearing was to review HRSA’s oversight of the 340B Drug Pricing Program, and how the program specifically impacts patients, providers, manufacturers and other stakeholders.  

Read More

Topics: Industry Updates, 340B, 340b compliance

About This Blog

The climate of provider reimbursement is ever-changing and this blog is intended to keep you up-to-date on the latest information regarding:

  • DSH Reimbursement
  • 340B Pharmacy Drug Discount Program
  • Compliance Issues
  • Litigation Surrounding Provider Reimbursement

Subscribe to Email Updates

Follow Us

Recent Posts